Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rieben

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Transfusion|November 1, 1993
Age dependency of ABO histo-blood group antibodies: reexamination of an old dogmaC Auf der Maur, M Hodel, U E Nydegger, et al.
Clinical Immunology and Immunopathology|July 1, 1996
Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patientsF Friedli, R Rieben, E Wegmüller, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugatesR Rieben, E Y Korchagina, N V Bovin, et al.
Xenotransplantation|October 3, 1999
Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy personsR Buonomano, C Tinguely, R Rieben, et al.
Xenotransplantation|May 1, 2001
Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serumB Gerber, C Tinguely, N V Bovin, et al.
Blood|January 28, 1999
Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammationR Rieben, A Roos, Y Muizert, et al.
British Journal of Haematology|September 15, 2005
Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric methodG Stussi, K Huggel, H U Lutz, et al.
European Neurology|March 31, 1998
Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controlsE Uetz-von Allmen, M Sturzenegger, R Rieben, et al.
Vox Sanguinis|August 7, 2009
In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparationsM Spycher, K Matozan, K Minnig, et al.
Transplantation|October 17, 2001
Successful management of a B-type cardiac allograft into an O-type man with 3(1/2)-year clinical follow-upP Mohacsi, R Rieben, G Sigurdsson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Transfusion|November 1, 1993
Age dependency of ABO histo-blood group antibodies: reexamination of an old dogmaC Auf der Maur, M Hodel, U E Nydegger, et al.
Clinical Immunology and Immunopathology|July 1, 1996
Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patientsF Friedli, R Rieben, E Wegmüller, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugatesR Rieben, E Y Korchagina, N V Bovin, et al.
Xenotransplantation|October 3, 1999
Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy personsR Buonomano, C Tinguely, R Rieben, et al.
Xenotransplantation|May 1, 2001
Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serumB Gerber, C Tinguely, N V Bovin, et al.
Blood|January 28, 1999
Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammationR Rieben, A Roos, Y Muizert, et al.
British Journal of Haematology|September 15, 2005
Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric methodG Stussi, K Huggel, H U Lutz, et al.
European Neurology|March 31, 1998
Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controlsE Uetz-von Allmen, M Sturzenegger, R Rieben, et al.
Vox Sanguinis|August 7, 2009
In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparationsM Spycher, K Matozan, K Minnig, et al.
Transplantation|October 17, 2001
Successful management of a B-type cardiac allograft into an O-type man with 3(1/2)-year clinical follow-upP Mohacsi, R Rieben, G Sigurdsson, et al.
Pageof 4